Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Trial of Preoperative Chemoradiation (Preop CRT) Followed by CapOx (Capecitabine Plus Oxaliplatin) Versus Preop CRT Alone for Locally Advanced Rectal Cancer (LARC)
Conditions
Interventions
Capecitabine Oxaliplatin
pelvic radiation capecitabine 5-fluorouracil
Locations
7
South Korea
National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Hallym University Sacred Heart Hospital
Anyang, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Severance Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Start Date
June 1, 2014
Primary Completion Date
September 1, 2017
Completion Date
December 1, 2019
Last Updated
September 13, 2017
NCT06696768
NCT05039801
NCT04704661
NCT05691465
NCT05198830
NCT06662786
Lead Sponsor
National Cancer Center, Korea
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions